— Know what they know.
Not Investment Advice

PB NYSE

Prosperity Bancshares, Inc.
1W: +3.8% 1M: +2.9% 3M: -4.3% YTD: +2.8% 1Y: +14.2% 3Y: +46.9% 5Y: +11.6%
$69.61
-0.13 (-0.19%)
After Hours: $69.66 (+0.05, +0.08%)
Weekly Expected Move ±2.3%
$66 $68 $70 $71 $73
NYSE · Financial Services · Banks - Regional · Tech Score Strong Buy · Power 67 · $8.4B mcap · 109M float · 1.01% daily turnover · Short 49% of daily vol
Credit Risk of going bust: not rated, financial company (lending is its business) Bonds: none of note held by US funds details ▾
Not rated: lending and leverage are a financial company's business, which the model misreads.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Income Trends

Revenue
$1.7B -0.2% ▼
5Y CAGR: +7.1%
Gross Profit
$1.2B +10.0% ▲
5Y CAGR: +2.5%
Operating Income
$694M +13.2% ▲
5Y CAGR: +1.5%
Net Income
$543M +13.2% ▲
5Y CAGR: +0.5%
EPS (Diluted)
$5.72 +13.3% ▲
5Y CAGR: +0.1%
EBITDA
$849M +31.2% ▲
5Y CAGR: +4.7%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$1.2B$1.2B$1.6B$1.7B$1.7B
YoY Growth-6.7%+4.4%+29.4%+12.0%-0.2%
Cost of Revenue$54M$90M$507M$606M$489M
Gross Profit$1.1B$1.1B$1.0B$1.1B$1.2B
Gross Margin95.3%92.5%67.4%65.2%71.9%
R&D Expenses$0$0$0$0$0
SG&A Expenses$328M$333M$376M$387M$390M
Operating Expenses$439M$447M$515M$523M$556M
Operating Income$660M$666M$534M$613M$694M
Operating Margin57.3%55.4%34.3%35.2%39.9%
Interest Expense$54M$90M$488M$597M$489M
Income Before Tax$660M$666M$534M$613M$694M
Tax Expense$140M$142M$115M$133M$151M
Net Income$519M$525M$419M$479M$543M
Net Margin45.1%43.6%26.9%27.5%31.2%
EPS (Diluted)$5.60$5.73$4.51$5.05$5.72
EBITDA$689M$694M$565M$647M$849M
Shares Outstanding93M92M93M95M95M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms